Open-Label, Fixed-Sequence, Crossover Study To Estimate The Pharmacokinetic Interaction Between Multiple Dose Maraviroc And Fosamprenavir/Ritonavir In Healthy Subjects.

Trial Profile

Open-Label, Fixed-Sequence, Crossover Study To Estimate The Pharmacokinetic Interaction Between Multiple Dose Maraviroc And Fosamprenavir/Ritonavir In Healthy Subjects.

Discontinued
Phase of Trial: Phase I

Latest Information Update: 14 Jan 2011

At a glance

  • Drugs Fosamprenavir; Maraviroc; Ritonavir
  • Indications HIV-1 infections
  • Focus Pharmacokinetics
  • Most Recent Events

    • 14 Jan 2011 Planned end date changed from 1 Dec 2010 to 1 Oct 2010 as reported by ClinicalTrials.gov.
    • 14 Jan 2011 Status changed from active, no longer recruiting to discontinued as reported by ClinicalTrials.gov.
    • 28 Oct 2010 Status changed from suspended to active, no longer recruiting as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top